Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 1409

1.

Hormonal therapy for breast cancer and diabetes incidence among postmenopausal women.

Santorelli ML, Hirshfield KM, Steinberg MB, Rhoads GG, Lin Y, Demissie K.

Ann Epidemiol. 2016 Apr 12. pii: S1047-2797(16)30085-0. doi: 10.1016/j.annepidem.2016.04.004. [Epub ahead of print]

PMID:
27157863
2.

Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.

Constantinou P, Dray-Spira R, Menvielle G.

BMC Cancer. 2016 Mar 31;16(1):255. doi: 10.1186/s12885-016-2295-0.

3.

The Immunocompromised Traveler.

Shah MK.

Oncology (Williston Park). 2016 Feb;30(2):142, 145-6, 159. No abstract available.

4.

Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) Linked Data Resource for Patient-Reported Outcomes Research in Older Adults with Cancer.

Kent EE, Malinoff R, Rozjabek HM, Ambs A, Clauser SB, Topor MA, Yuan G, Burroughs J, Rodgers AB, DeMichele K.

J Am Geriatr Soc. 2016 Jan;64(1):186-92. doi: 10.1111/jgs.13888.

PMID:
26782871
5.

The decision-making process for senior cancer patients: treatment allocation of older women with operable breast cancer in the UK.

Morgan JL, Richards P, Zaman O, Ward S, Collins K, Robinson T, Cheung KL, Audisio RA, Reed MW, Wyld L; Bridging the Age Gap in Breast Cancer Trial Management Team.

Cancer Biol Med. 2015 Dec;12(4):308-15. doi: 10.7497/j.issn.2095-3941.2015.0080.

6.

Effect of Postmastectomy Radiation on Survival of AJCC pN2/N3 Breast Cancer Patients.

Shi Z, Peddi P, Burton G, Mills G, Shi R.

Anticancer Res. 2016 Jan;36(1):261-9.

PMID:
26722052
7.

Substitution scenario in follow-up of chronic cancer patients in primary care: prevalence, disease duration and estimated extra consultation time.

van Dipten C, Olde Hartman TC, Biermans MC, Assendelft WJ.

Fam Pract. 2016 Feb;33(1):4-9. doi: 10.1093/fampra/cmv098. Epub 2015 Dec 20.

PMID:
26691380
8.

Randomized controlled trial of stereotactic 11-G vacuum-assisted core biopsy for the diagnosis and management of mammographic microcalcification.

Bundred SM, Maxwell AJ, Morris J, Lim YY, Harake MJ, Whiteside S, Bundred NJ.

Br J Radiol. 2016;89(1058):20150504. doi: 10.1259/bjr.20150504. Epub 2015 Dec 14.

PMID:
26654214
9.

[Emotional and psychosomatic disorder among female patients undergoing breast cancer diagnosis].

Strójwąs K, Florkowski A, Jeżowska-Smorąg I, Gądek I, Zboralski K, Macander M, Przybyszewska M, Wierzbiński P.

Pol Merkur Lekarski. 2015 Nov;39(233):287-91. Polish.

PMID:
26637093
10.

Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.

de Glas NA, Kiderlen M, Vandenbroucke JP, de Craen AJ, Portielje JE, van de Velde CJ, Liefers GJ, Bastiaannet E, Le Cessie S.

J Natl Cancer Inst. 2015 Nov 26;108(5). pii: djv366. doi: 10.1093/jnci/djv366. Print 2016 May.

PMID:
26614095
11.

Prevalence of Preexisting Cardiovascular Disease in Patients With Different Types of Cancer: The Unmet Need for Onco-Cardiology.

Al-Kindi SG, Oliveira GH.

Mayo Clin Proc. 2016 Jan;91(1):81-3. doi: 10.1016/j.mayocp.2015.09.009. Epub 2015 Nov 18.

PMID:
26602599
12.

Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.

Killelea BK, Yang VQ, Wang SY, Hayse B, Mougalian S, Horowitz NR, Chagpar AB, Pusztai L, Lannin DR.

J Clin Oncol. 2015 Dec 20;33(36):4267-76. doi: 10.1200/JCO.2015.63.7801. Epub 2015 Nov 23.

PMID:
26598753
13.

Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast Cancer.

Epstein AJ, Wong YN, Mitra N, Vachani A, Hin S, Yang L, Smith-McLallen A, Armstrong K, Groeneveld PW.

J Clin Oncol. 2015 Dec 20;33(36):4259-67. doi: 10.1200/JCO.2015.61.9023. Epub 2015 Nov 23.

PMID:
26598749
14.

Diabetics at increased risk of advanced breast cancer.

Azvolinsky A.

Oncology (Williston Park). 2015 Sep;29(9):650. No abstract available.

PMID:
26495509
15.

Breast conservation versus mastectomy for patients with T3 primary tumors (>5 cm): A review of 5685 medicare patients.

Bleicher RJ, Ruth K, Sigurdson ER, Daly JM, Boraas M, Anderson PR, Egleston BL.

Cancer. 2016 Jan 1;122(1):42-9. doi: 10.1002/cncr.29726. Epub 2015 Oct 19.

PMID:
26479066
16.

The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study.

Goldhar HA, Yan AT, Ko DT, Earle CC, Tomlinson GA, Trudeau ME, Krahn MD, Krzyzanowska MK, Pal RS, Brezden-Masley C, Gavura S, Lien K, Chan KK.

J Natl Cancer Inst. 2015 Oct 16;108(1). pii: djv301. doi: 10.1093/jnci/djv301. Print 2016 Jan.

PMID:
26476433
17.

Predicting Late-stage Breast Cancer Diagnosis and Receipt of Adjuvant Therapy: Applying Current Spatial Access to Care Methods in Appalachia.

Donohoe J, Marshall V, Tan X, Camacho FT, Anderson R, Balkrishnan R.

Med Care. 2015 Nov;53(11):980-8. doi: 10.1097/MLR.0000000000000432.

PMID:
26465126
18.

The impact of patient comorbidity on cancer stage at diagnosis.

Gurney J, Sarfati D, Stanley J.

Br J Cancer. 2015 Nov 3;113(9):1375-80. doi: 10.1038/bjc.2015.355. Epub 2015 Oct 13.

PMID:
26461060
19.

Secondary Primary Malignancy Risk in Patients With Ovarian Cancer in Taiwan: A Nationwide Population-Based Study.

Hung YP, Liu CJ, Hu YW, Chen MH, Li CP, Yeh CM, Chiou TJ, Chen TJ, Yang MH, Chao Y.

Medicine (Baltimore). 2015 Sep;94(38):e1626. doi: 10.1097/MD.0000000000001626.

20.

Use of Preoperative Magnetic Resonance Imaging for Breast Cancer: A Canadian Population-Based Study.

Arnaout A, Catley C, Booth CM, McInnes M, Graham I, Kumar V, Simos D, Van Walraven C, Clemons M.

JAMA Oncol. 2015 Dec;1(9):1238-50. doi: 10.1001/jamaoncol.2015.3018.

PMID:
26402040
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk